Copy to clipboard 
Synergy Biomedical, a developer of bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. This study was conducted by Synergy’s founder, Mark Borden Ph.D. and a team of clinical and basic science collaborators, and is published in the Journal of Biomedical Materials Research, Part B: Applied Biomaterials.
The results of the study demonstrate that the bone formation properties of a clinically accepted bone graft material, bioactive glass, can be optimized and improved by controlling particle shape and size. This concept led to the use of spherical bioactive glass particles in all of Synergy’s products and is the foundation of the company’s patented BioSphere® Technology.
“This pivotal paper documents the innovative work conducted in the early history of Synergy Biomedical that identified bioactive glass spheres as an optimal particle for bone regeneration,” stated Kevin Booth, CEO of Synergy Biomedical. “The study highlights Synergy’s strategic approach to understand and optimize biomaterial properties in order to bring next-generation bone graft products to the market. This strategy has differentiated our products and technology in a market full of first-generation bone graft materials.”
The study highlighted the following key concepts:
- Bioactive glass stimulates cellular healing and forms a bioactive layer on its surface due to the release of ions from the glass as it slowly dissolves in the body
- Bone formation between bioactive glass particles is dependent on inter-particle spacing and is directly controlled by particle shape and size
- Bioactive glass spheres were successfully fabricated and maintained the chemical and bioactive properties of 45S5 bioactive glass
- Bioactive glass spheres provided direct control over ion release and inter-particle spacing. Optimization of these particles can improve the bone healing properties of the glass.
Source: Synergy Biomedical, LLC
Synergy Biomedical, a developer of bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. This study was conducted by Synergy’s founder, Mark Borden Ph.D. and a team of clinical and...
Synergy Biomedical, a developer of bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. This study was conducted by Synergy’s founder, Mark Borden Ph.D. and a team of clinical and basic science collaborators, and is published in the Journal of Biomedical Materials Research, Part B: Applied Biomaterials.
The results of the study demonstrate that the bone formation properties of a clinically accepted bone graft material, bioactive glass, can be optimized and improved by controlling particle shape and size. This concept led to the use of spherical bioactive glass particles in all of Synergy’s products and is the foundation of the company’s patented BioSphere® Technology.
“This pivotal paper documents the innovative work conducted in the early history of Synergy Biomedical that identified bioactive glass spheres as an optimal particle for bone regeneration,” stated Kevin Booth, CEO of Synergy Biomedical. “The study highlights Synergy’s strategic approach to understand and optimize biomaterial properties in order to bring next-generation bone graft products to the market. This strategy has differentiated our products and technology in a market full of first-generation bone graft materials.”
The study highlighted the following key concepts:
- Bioactive glass stimulates cellular healing and forms a bioactive layer on its surface due to the release of ions from the glass as it slowly dissolves in the body
- Bone formation between bioactive glass particles is dependent on inter-particle spacing and is directly controlled by particle shape and size
- Bioactive glass spheres were successfully fabricated and maintained the chemical and bioactive properties of 45S5 bioactive glass
- Bioactive glass spheres provided direct control over ion release and inter-particle spacing. Optimization of these particles can improve the bone healing properties of the glass.
Source: Synergy Biomedical, LLC
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
